NCT05394363 Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents
| NCT ID | NCT05394363 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Murdoch Childrens Research Institute |
| Condition | Mental Health |
| Study Type | OBSERVATIONAL |
| Enrollment | 150,000 participants |
| Start Date | 2021-10-04 |
| Primary Completion | 2033-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150,000 participants in total. It began in 2021-10-04 with a primary completion date of 2033-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Generation Victoria (GenV) is a longitudinal, population-based study of Victorian children and their parents that will bring together data on a wide range of conditions ,exposures and outcomes. GenV blends study-collected, study-enhanced and linked data. It will be multi-purpose, supporting observational, interventional, health services and policy research within the same cohort. It is designed to address physical, mental and social issues experienced during childhood, as well as the antecedents of a wide range of diseases of ageing. It seeks to generate translatable evidence (prediction, prevention, treatments, services) to improve future wellbeing and reduce the future disease burden of children and adults. The GenV Cohort 2020s is open to all children born over a two-year period, and their parents, residing in the state of Victoria Australia. The GenV Cohort 2020s is preceded by an Advance Cohort of children born between 5 Dec 2020 and 3 October 2021, and their parents. This comprises all families recruited at GenV's Vanguard hospital (Joan Kirner Women's and Children's) and at birthing hospitals throughout Victoria as GenV scaled up to commence recruiting for the GenV Cohort 2020s. The Advance Cohort have ongoing and full participation in GenV for their lifetime unless they withdraw but may have less complete data and biosamples.
Eligibility Criteria
Inclusion Criteria (Children): * Birth date between 4th October 2021 and 3rd October 2023 * Live at the time of recruitment * Residing in Victoria at the time of recruitment * Has a legally acceptable representative capable of understanding the informed consent document and providing consent on the child's behalf, who provides a signed and dated informed consent form (e.g. a parent/guardian) Inclusion Criteria (Adults): * Be a parent or guardian of a child who meets the eligibility criteria above * Provide a signed and dated informed consent form or have a legally acceptable representative capable of understanding the informed consent document and providing consent on the participant's behalf. Exclusion criteria: * Children who are deceased at the time of recruitment (i.e. still born or died after birth) and their parents/guardians * Families unable to provide informed consent in any of the languages available
Contact & Investigator
Melissa Wake, MBChB, FRACP, FAHMS, MD
PRINCIPAL INVESTIGATOR
Murdoch Childrens Research Institute
Frequently Asked Questions
Who can join the NCT05394363 clinical trial?
This trial is open to participants of all sexes, aged 1 Day or older, studying Mental Health. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05394363 currently recruiting?
Yes, NCT05394363 is actively recruiting participants. Contact the research team at genv@mcri.edu.au for enrollment information.
Where is the NCT05394363 trial being conducted?
This trial is being conducted at Parkville, Australia.
Who is sponsoring the NCT05394363 clinical trial?
NCT05394363 is sponsored by Murdoch Childrens Research Institute. The principal investigator is Melissa Wake, MBChB, FRACP, FAHMS, MD at Murdoch Childrens Research Institute. The trial plans to enroll 150,000 participants.